Literature DB >> 12438570

Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis.

Rasheed Ahmad1, Sardar T A Sindhu, Emil Toma, Richard Morisset, Ali Ahmad.   

Abstract

Originally identified as the gamma interferon-inducing factor, interleukin-18 (IL-18) was rediscovered as a proinflammatory cytokine related to the IL-1 family of cytokines that plays an important role in both innate and adaptive immune responses against viruses and intracellular pathogens. Despite its importance in inducing and regulating immune responses, relatively little is known about its production in HIV infection. We report here significantly (P < 0.05) elevated levels of this cytokine in the sera of human immunodeficiency virus (HIV)-infected/AIDS patients compared to those of HIV-seronegative healthy persons. Surprisingly, the peripheral blood mononuclear cells (PBMC) from HIV-infected/AIDS patients were compromised in the ability to upregulate IL-18 gene expression and produce this cytokine with and without lipopolysaccharide (LPS) stimulation. A significant positive correlation (P < 0.05) existed between the concentration of IL-18 in serum and its production from PBMC of HIV-seronegative healthy individuals but not those of HIV-infected/AIDS patients. Furthermore, the patients' PBMC expressed relatively reduced levels of activated caspase-1 constitutively as well as in response to LPS stimulation. Our data suggest the involvement of transforming growth factor beta (TGF-beta) in suppressing IL-18 production from the patients' PBMC for the following reasons. (i) In in vitro studies it suppressed the production of IL-18 from PBMC. (ii) Its levels were significantly higher in the plasma of patients compared to that of control subjects. (iii) A significant negative correlation existed between the concentrations of TGF-beta in plasma and of IL-18 in serum of the patients. The elevated levels of IL-18 in the serum of HIV-infected individuals may contribute to AIDS pathogenesis, whereas its compromised production from their PBMC in response to stimuli may reduce their innate defense to opportunistic intracellular pathogens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438570      PMCID: PMC136707          DOI: 10.1128/jvi.76.24.12448-12456.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils.

Authors:  T Yoshimoto; H Tsutsui; K Tominaga; K Hoshino; H Okamura; S Akira; W E Paul; K Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  The role of IL-18 in innate immunity.

Authors:  S Akira
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

3.  Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus.

Authors:  C Chougnet; T A Wynn; M Clerici; A L Landay; H A Kessler; J Rusnak; G P Melcher; A Sher; G M Shearer
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

4.  Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes.

Authors:  S Stoll; G Müller; M Kurimoto; J Saloga; T Tanimoto; H Yamauchi; H Okamura; J Knop; A H Enk
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

Review 5.  Cytokine profiles in HIV type 1 disease and protection.

Authors:  G M Shearer; M Clerici
Journal:  AIDS Res Hum Retroviruses       Date:  1998-06       Impact factor: 2.205

6.  Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.

Authors:  L D Giavedoni; M C Velasquillo; L M Parodi; G B Hubbard; V L Hodara
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  A proinflammatory role for IL-18 in rheumatoid arthritis.

Authors:  J A Gracie; R J Forsey; W L Chan; A Gilmour; B P Leung; M R Greer; K Kennedy; R Carter; X Q Wei; D Xu; M Field; A Foulis; F Y Liew; I B McInnes
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

8.  Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases.

Authors:  J Xu; A Ahmad; M D'Addario; L Knafo; J F Jones; U Prasad; R Dolcetti; E Vaccher; J Menezes
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

9.  Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme.

Authors:  Y Gu; K Kuida; H Tsutsui; G Ku; K Hsiao; M A Fleming; N Hayashi; K Higashino; H Okamura; K Nakanishi; M Kurimoto; T Tanimoto; R A Flavell; V Sato; M W Harding; D J Livingston; M S Su
Journal:  Science       Date:  1997-01-10       Impact factor: 47.728

10.  Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

Authors:  T Ghayur; S Banerjee; M Hugunin; D Butler; L Herzog; A Carter; L Quintal; L Sekut; R Talanian; M Paskind; W Wong; R Kamen; D Tracey; H Allen
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

View more
  38 in total

Review 1.  New players in cytokine control of HIV infection.

Authors:  Massimo Alfano; Andrea Crotti; Elisa Vicenzi; Guido Poli
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

Review 2.  Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.

Authors:  Davide Gibellini; Alberto Clò; Silvia Morini; Anna Miserocchi; Cristina Ponti; Maria Carla Re
Journal:  World J Virol       Date:  2013-05-12

3.  IL-18 gene promoter polymorphism is involved in HIV-1 infection in a Brazilian pediatric population.

Authors:  Ludovica Segat; Daiana Bevilacqua; Michele Boniotto; Luiz C Arraes; Paulo R de Souza; Josè L de Lima Filho; Sergio Crovella
Journal:  Immunogenetics       Date:  2006-05-05       Impact factor: 2.846

4.  Comparison of Th1 and Th2 responses in non-healing and healing patients with cutaneous leishmaniasis.

Authors:  Maryam Shahi; Masoud Mohajery; Seyyed Ali Akbar Shamsian; Hossein Nahrevanian; Seyyed Mohammad Javad Yazdanpanah
Journal:  Rep Biochem Mol Biol       Date:  2013-04

Review 5.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 6.  The macrophage in HIV-1 infection: from activation to deactivation?

Authors:  Georges Herbein; Audrey Varin
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

7.  Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.

Authors:  Jacob D Estes; Levelle D Harris; Nichole R Klatt; Brian Tabb; Stefania Pittaluga; Mirko Paiardini; G Robin Barclay; Jeremy Smedley; Rhonda Pung; Kenneth M Oliveira; Vanessa M Hirsch; Guido Silvestri; Daniel C Douek; Christopher J Miller; Ashley T Haase; Jeffrey Lifson; Jason M Brenchley
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

8.  Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet.

Authors:  Jennifer H Yearley; Dongling Xia; Christine B Pearson; Angela Carville; Richard P Shannon; Keith G Mansfield
Journal:  Lab Invest       Date:  2009-04-20       Impact factor: 5.662

9.  Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients.

Authors:  E Stylianou; V Bjerkeli; A Yndestad; L Heggelund; T Waehre; J K Damås; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

Review 10.  CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure.

Authors:  Afam A Okoye; Louis J Picker
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.